Cargando…
Different conbercept injection strategies for the treatment of exudative age-related macular degeneration: A retrospective cohort study
Conbercept is a novel anti-vascular endothelial growth factor for the treatment of age-related macular degeneration (AMD). The most optimal injection strategy is unknown. To assess the effectiveness of intravitreal injection of conbercept using the 3 + pro re nata (PRN) and 3 + Q3 M strategies for t...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035057/ https://www.ncbi.nlm.nih.gov/pubmed/32049795 http://dx.doi.org/10.1097/MD.0000000000019007 |